Investors & Advocates FDA Approval of OGM
Post# of 61
(Total Views: 101)
Posted On: 11/28/2024 1:48:46 PM
There’s a new sheriff is in town: Robert F. Kennedy Jr. Robert F. Kennedy Jr. has been quite vocal about his plans to overhaul the FDA.
When researchers, clinicians, and investors come together to advocate for a promising technology, it can bring attention to its potential benefits and the urgency of its approval.
Public pressure, combined with robust research and evidence (Worldwide acceptance), can expedite the regulatory process. It's important to continue raising awareness and ensuring that the voices of those who support OGM are heard.
Here's a draft of an open letter you can use to advocate for the approval of Bionano Genomics' Optical Genome Mapping (OGM):
[Your Name] [Your Address] [City, State, ZIP Code] [Email Address] [Date]
Dr. Jeffrey Shuren
Director, Center for Devices and Radiological Health Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993-000
Dear Dr. Shuren,
I am writing to express my strong support for the approval of Bionano Genomics' Optical Genome Mapping (OGM) technology.
As a [researcher/investor/clinician/advocate], I believe that OGM has the potential to revolutionize genomic analysis and diagnostics, providing significant benefits to patients and the healthcare community.
The acceptance of OGM by prestigious institutions such as the Mayo Clinic and Johns Hopkins underscores its credibility and potential. Furthermore, extensive testing and research conducted worldwide have demonstrated the efficacy and safety of this technology.
However, despite these promising developments, the approval process for OGM appears to be facing unnecessary delays.
I urge the FDA, specifically the Office of Health Technology 7 (OHT7), to prioritize the evaluation and approval of OGM. The timely approval of this technology is crucial for advancing genomic research and improving patient outcomes.
Thank you for your attention to this matter. I look forward to a positive resolution and the continued advancement of genomic science.
Sincerely, [Your Name]
(lets start a ground swell of getting the FDA to approve OGM)
When researchers, clinicians, and investors come together to advocate for a promising technology, it can bring attention to its potential benefits and the urgency of its approval.
Public pressure, combined with robust research and evidence (Worldwide acceptance), can expedite the regulatory process. It's important to continue raising awareness and ensuring that the voices of those who support OGM are heard.
Here's a draft of an open letter you can use to advocate for the approval of Bionano Genomics' Optical Genome Mapping (OGM):
[Your Name] [Your Address] [City, State, ZIP Code] [Email Address] [Date]
Dr. Jeffrey Shuren
Director, Center for Devices and Radiological Health Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993-000
Dear Dr. Shuren,
I am writing to express my strong support for the approval of Bionano Genomics' Optical Genome Mapping (OGM) technology.
As a [researcher/investor/clinician/advocate], I believe that OGM has the potential to revolutionize genomic analysis and diagnostics, providing significant benefits to patients and the healthcare community.
The acceptance of OGM by prestigious institutions such as the Mayo Clinic and Johns Hopkins underscores its credibility and potential. Furthermore, extensive testing and research conducted worldwide have demonstrated the efficacy and safety of this technology.
However, despite these promising developments, the approval process for OGM appears to be facing unnecessary delays.
I urge the FDA, specifically the Office of Health Technology 7 (OHT7), to prioritize the evaluation and approval of OGM. The timely approval of this technology is crucial for advancing genomic research and improving patient outcomes.
Thank you for your attention to this matter. I look forward to a positive resolution and the continued advancement of genomic science.
Sincerely, [Your Name]
(lets start a ground swell of getting the FDA to approve OGM)
(0)
(0)